Trials / Conditions / Alopecia Areata(AA)

Alopecia Areata(AA)

13 registered clinical trials studyying Alopecia Areata(AA) — 5 currently recruiting.

Status	Trial	Sponsor	Phase
Enrolling By Invitation	Association of Serum VEGF-A and VCAM-1 Levels With Nailfold Capilleroscopic Alterations in Alopecia Areata NCT07499713	Istanbul Training and Research Hospital	—
Recruiting	Cyclosporine Or Methotrexate for Pediatric Alopecia Areata: Routine Clinical Care Effectiveness Study NCT07381556	Erasmus Medical Center	Phase 4
Recruiting	HCW9302 (Interleukin-2 Fusion Protein) for Alopecia Areata NCT07049328	HCW Biologics	Phase 1
Recruiting	A Clinical Study to Evaluate the Safety, Tolerability, Pharmacokinetics and Preliminary Efficacy of ALD-102 So NCT06826196	Aldena Therapeutics	Phase 1 / Phase 2
Recruiting	A Phase 1 Trial to Evaluate the Safety, Tolerability, Pharmacodynamics, Pharmacokinetics, and Immunogenicity o NCT06799520	Otsuka Pharmaceutical Development & Commercialization, Inc.	Phase 1
Completed	Impact of NR3C1 rs41423247 (BclI) Polymorphism on Disease Severity in Alopecia Areata NCT07455708	Benha University	—
Completed	A Study to Evaluate the Safety, Pharmacokinetics and Efficacy of IMG-007 in Adult Alopecia Areata Participants NCT06060977	Inmagene LLC	Phase 1 / Phase 2
Completed	To Compare the Efficacy of Weekly Azathioprine Pulse Versus Betamethasone Oral Mini-Pulse in the Treatment of NCT06786689	Sheikh Zayed Medical College	Phase 2
Unknown	A Study With Jaktinib Hydrochloride Cream Applied Topically to Subjects With Alopecia Areata NCT04445363	Suzhou Zelgen Biopharmaceuticals Co.,Ltd	Phase 1 / Phase 2
Completed	Rhofanib® (Tofacitinib) Safety and Effectiveness Evaluation NCT07101471	NanoAlvand	—
Completed	Tofacitnib for the Treatment of Alopecia Areata and Variants NCT02197455	Yale University	Phase 2